Alnylam Pharmaceuticals Inc. (ALNY): Price and Financial Metrics
ALNY Price/Volume Stats
Current price | $307.99 | 52-week high | $310.22 |
Prev. close | $304.67 | 52-week low | $152.30 |
Day low | $300.97 | Volume | 571,800 |
Day high | $308.02 | Avg. volume | 894,523 |
50-day MA | $269.33 | Dividend yield | N/A |
200-day MA | $263.31 | Market Cap | 40.16B |
ALNY Stock Price Chart Interactive Chart >
Alnylam Pharmaceuticals Inc. (ALNY) Company Bio
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics[3] for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.[4] In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. (Source:Wikipedia)
ALNY Price Returns
1-mo | 7.95% |
3-mo | 21.68% |
6-mo | 24.90% |
1-year | 92.03% |
3-year | 128.45% |
5-year | 132.87% |
YTD | 30.89% |
2024 | 22.94% |
2023 | -19.46% |
2022 | 40.14% |
2021 | 30.48% |
2020 | 12.85% |
Continue Researching ALNY
Want to do more research on Alnylam Pharmaceuticals Inc's stock and its price? Try the links below:Alnylam Pharmaceuticals Inc (ALNY) Stock Price | Nasdaq
Alnylam Pharmaceuticals Inc (ALNY) Stock Quote, History and News - Yahoo Finance
Alnylam Pharmaceuticals Inc (ALNY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...